COPD clinical trials in El Paso, TX
5 studies for COPD are looking for participants at sites in and around El Paso (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- El Paso Pulmonary Association- Site Number : 8400033, El Paso
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
RecruitingPhase 2
- Research Site, El Paso
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
RecruitingPhase 3
- Research Site, El Paso
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RecruitingPhase 3
- Research Site, El Paso
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
RecruitingPhase 3
- GSK Investigational Site, El Paso
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA22 studies
- Miami, FL18 studies
- Birmingham, AL18 studies
- Boston, MA17 studies
- Houston, TX15 studies
- Orlando, FL15 studies
- Chicago, IL14 studies
- Pittsburgh, PA13 studies
- Baltimore, MD13 studies
- Dallas, TX12 studies
- New York City, NY11 studies
- Ann Arbor, MI10 studies
Other studies in El Paso
- Obesity10 studies
- Overweight8 studies
- Heart Failure7 studies
- Non-Small Cell Lung Cancer6 studies
- Breast Cancer6 studies
- Metastatic Cancer5 studies
- Lung Cancer4 studies
- Cancer (all types)4 studies
- Alzheimer's Disease4 studies
- Burkitt Lymphoma4 studies
- Idiopathic Pulmonary Fibrosis4 studies
- Lupus4 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.